J Allergy Clin Immunol Pract
June 2024
Background: Biologic modifiers targeting type 2 (T2) airway inflammation are effective in reducing asthma exacerbation. However, real-world and comparative effectiveness studies remain limited.
Objective: To examine and compare the real-world impact of anti-T2 asthma biologics.